Czakó László, Tiszlavicz László, Takács Róbert, Baradnay Gellért, Lonovics János, Cserni Gábor, Závodná Katarina, Bartosova Zdena
Orv Hetil. 2005 May 15;146(20):1009-16.
Hereditary nonpolyposis colorectal cancer is an inherited disease characterized by onset at an early age, an excess of synchronous and metachronous large bowel tumors and a variety of extracolorectal malignancies. Basal and squamous cell carcinomas of the skin are not customarily included in the tumor spectrum of the syndrome. The disease is caused by a germline mutation in one of the DNA mismatch repair genes, most commonly MSH2 or MLH1, and typically presents with microsatellite instability and frequent loss of mismatch repair protein expression in the tumor tissue.
The case of a 62-year old woman who had a history of colon cancer at the age of 46 years, endometrial cancer at the age of 56 years, baso-squamous, and squamous cell cancer of the face at the ages of 53, 54, 62 and 58 years, respectively, and rectal cancer at 60 is reported. Her family fulfills the Amsterdam criteria for the diagnosis of hereditary nonpolyposis colorectal cancer. The baso-squamous cell, the squamous cell, the endometrial and the rectal cancers were assessed for the microsatellite instability status and the expression of the MSH2 and MLH1 mismatch repair proteins, and the p53 tumor suppressor protein by immunohistochemistry. Mutational screening using an automated capillary DNA sequencer was performed by the direct genomic sequencing of 17 fragments of the MSH2 gene, which covers promoter, all exons and flanking intronic regions.
All cancers displayed microsatellite instability and were positive for the p53 protein. The immunohistochemical staining in the baso-squamous cell, the squamous cell, the rectal and endometrial cancers were negative for MSH2 and positive for MLH1 proteins. DNA sequencing analysis revealed a mutation c.2292G > A in exon 14 of the MSH2 gene, which is altering the 764. amino acid, the tryptophan to STOP codon (p.W764X). Thus the MSH2 protein is presumably truncated by 171 aminoacids.
To the best of authors' knowledge, this is the first molecular characterization of a Hungarian hereditary nonpolyposis colorectal cancer family. According to the Human Mutation Database and International Collaborative Group of HNPCC Database, this mutation is novel, has not been reported previously. Cutaneous baso-squamous and squamous cell cancers may present as part of the HNPCC phenotype. Detection of the loss of mismatch repair protein expression and mismatch repair gene mutation mapping, represents a significant improvement of the diagnosis of this syndrome in Hungary. These examinations identify the mutation carriers who are at an increased risk of developing cancers.
遗传性非息肉病性结直肠癌是一种遗传性疾病,其特征为发病年龄早、同时性和异时性大肠肿瘤过多以及多种结直肠外恶性肿瘤。皮肤基底细胞癌和鳞状细胞癌通常不包括在该综合征的肿瘤谱中。该疾病由DNA错配修复基因之一的种系突变引起,最常见的是MSH2或MLH1,并且通常在肿瘤组织中表现为微卫星不稳定性和错配修复蛋白表达频繁缺失。
报告了一名62岁女性的病例,她在46岁时患结肠癌,56岁时患子宫内膜癌,分别在53岁、54岁、62岁和58岁时患面部基底鳞状细胞癌和鳞状细胞癌,60岁时患直肠癌。她的家族符合遗传性非息肉病性结直肠癌的阿姆斯特丹诊断标准。通过免疫组织化学评估基底鳞状细胞癌、鳞状细胞癌、子宫内膜癌和直肠癌的微卫星不稳定性状态以及MSH2和MLH1错配修复蛋白以及p53肿瘤抑制蛋白的表达。使用自动毛细管DNA测序仪通过对MSH2基因的17个片段进行直接基因组测序来进行突变筛查,这些片段涵盖启动子、所有外显子和侧翼内含子区域。
所有癌症均显示微卫星不稳定性,并且p53蛋白呈阳性。基底鳞状细胞癌、鳞状细胞癌、直肠癌和子宫内膜癌的免疫组织化学染色显示MSH2为阴性,MLH1蛋白为阳性。DNA测序分析显示MSH2基因第14外显子存在c.2292G > A突变,该突变改变了第764位氨基酸,将色氨酸变为终止密码子(p.W764X)。因此,MSH2蛋白可能被截短了171个氨基酸。
据作者所知,这是匈牙利遗传性非息肉病性结直肠癌家族的首次分子特征描述。根据人类突变数据库和HNPCC数据库国际协作组,该突变是新的,以前未曾报道过。皮肤基底鳞状细胞癌和鳞状细胞癌可能作为HNPCC表型的一部分出现。检测错配修复蛋白表达缺失和错配修复基因突变定位,代表了匈牙利对该综合征诊断的重大改进。这些检查可识别患癌风险增加的突变携带者。